%0 Journal Article
%T Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome
%A Hiroaki Kusaka
%A Hisao Ogawa
%A Nobutaka Koibuchi
%A Shokei Kim-Mitsuyama
%A Yu Hasegawa
%J Archive of "Cardiovascular Diabetology".
%D 2016
%R 10.1186/s12933-016-0473-7
%X The potential benefit of SGLT2 inhibitors in metabolic syndrome is with prediabetic stage unclear. This work was undertaken to investigate the non-glycemic effect of empagliflozin on metabolic syndrome rats with prediabetes
%K Cardiac protection
%K Oxidative stress
%K Inflammation
%K Metabolic syndrome
%K Prediabetes
%K Natriuresis
%K Adipose tissue
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106779/